DC
IONS icon

Deere & Company’s Ionis Pharmaceuticals IONS Stock Holding History

Deere & Company’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,059
Closed -$561K – 1079
2015
Q4 		$561K Hold
9,059
– – 0.03% 491
2015
Q3 		$366K Buy
+9,059
New +$469K 0.02% 695
2014
Q1 		– Sell
-10,927
Closed -$435K – 995
2013
Q4 		$435K Buy
10,927
+3,236
+42% +$115K 0.02% 692
2013
Q3 		$289K Buy
+7,691
New +$230K 0.02% 770

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Deere & Company's IONS Position: Q1 2016 in Review

Deere & Company sold out of Ionis Pharmaceuticals (IONS) in Q1 2016, closing a stake of 9,059 shares — an estimated $561K sold.

Deere & Company first reported a position in IONS in Q3 2013 and held it in 4 quarters. The position peaked at $561K in Q4 2015. 314 funds tracked by Wall St. Rank hold IONS as of Q1 2016.

  • Deere & Company reported no remaining Ionis Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 9,059 Ionis Pharmaceuticals shares in Q1 2016, an estimated $561K.
  • Deere & Company first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • Deere & Company's Ionis Pharmaceuticals position peaked at $561K in Q4 2015.
  • 314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.